ClearPoint Neuro, Inc.
CLPTNASDAQHealthcare● Active
$13.38
+$0.49(+3.80%)
Market Cap$401260353
P/E Ratio—
52W High$30.1
52W Low$8.27
ClearPoint Neuro, Inc. (CLPT) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CLPT · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($25.54M) | ($18.91M) | ($22.09M) | ($16.43M) | ($14.41M) |
| Depreciation & Amort. | $0.98M | $1.90M | $1.51M | $0.78M | $0.69M |
| Stock-Based Comp. | $8.18M | $6.91M | $6.08M | $0.00M | $2.08M |
| Change in Working Capital | ($9.81M) | $1.40M | ($1.40M) | ($4.29M) | ($1.68M) |
| Net Cash from Operations | ($23.93M) | ($8.95M) | ($13.72M) | ($16.17M) | ($12.70M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.52M) | ($0.28M) | ($0.72M) | ($0.25M) | ($0.17M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | ($21.59M) | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $12.00M | $0.00M |
| Net Cash from Investing | $0.61M | ($0.28M) | $8.95M | ($10.74M) | ($0.17M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | ($0.21M) | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $48.09M | ($10.00M) | $0.00M | $0.00M | $0.00M |
| Net Cash from Financing | $50.18M | $6.19M | $0.30M | $0.41M | $46.88M |
| Free Cash Flow | |||||
| Free Cash Flow | ($24.45M) | ($9.22M) | ($14.44M) | ($16.42M) | ($12.87M) |
| FCF Margin %(computed) | -66.12% | -29.39% | -60.27% | -79.90% | -78.93% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more ClearPoint Neuro, Inc. data
About ClearPoint Neuro, Inc. (CLPT) Cash Flow Statement
ClearPoint Neuro, Inc. generated operating cash flow of ($0.02B) and free cash flow of ($0.02B) for 2025 — a FCF margin of -66.12%. Capital expenditure was ($0.00B).
Frequently asked questions
CLPT · 4 questionsClearPoint Neuro, Inc. generated free cash flow of ($0.02B) for 2025, down 165.0% year-over-year.
CLPT free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10